- Home
- GOSS vs UPXI Comparison
GOSS vs UPXI Comparison
Compare GOSS & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- UPXI
- Stock Information
- Founded
- GOSS 2015
- UPXI 2018
- Country
- GOSS United States
- UPXI United States
- Employees
- GOSS N/A
- UPXI N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- GOSS Health Care
- UPXI Health Care
- Exchange
- GOSS Nasdaq
- UPXI Nasdaq
- Market Cap
- GOSS 347.8M
- UPXI 481.8M
- IPO Year
- GOSS 2019
- UPXI 2021
- Fundamental
- Price
- GOSS $2.47
- UPXI $7.23
- Analyst Decision
- GOSS Strong Buy
- UPXI
- Analyst Count
- GOSS 4
- UPXI 0
- Target Price
- GOSS $8.50
- UPXI N/A
- AVG Volume (30 Days)
- GOSS 3.1M
- UPXI 8.1M
- Earning Date
- GOSS 08-05-2025
- UPXI 05-16-2025
- Dividend Yield
- GOSS N/A
- UPXI N/A
- EPS Growth
- GOSS N/A
- UPXI N/A
- EPS
- GOSS N/A
- UPXI N/A
- Revenue
- GOSS $40,237,000.00
- UPXI $16,562,327.00
- Revenue This Year
- GOSS N/A
- UPXI $299.03
- Revenue Next Year
- GOSS $30.65
- UPXI N/A
- P/E Ratio
- GOSS N/A
- UPXI N/A
- Revenue Growth
- GOSS N/A
- UPXI 1378.83
- 52 Week Low
- GOSS $0.66
- UPXI $1.90
- 52 Week High
- GOSS $2.65
- UPXI $22.57
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- UPXI 51.85
- Support Level
- GOSS $2.38
- UPXI $6.16
- Resistance Level
- GOSS $2.65
- UPXI $9.12
- Average True Range (ATR)
- GOSS 0.15
- UPXI 0.97
- MACD
- GOSS 0.03
- UPXI 0.10
- Stochastic Oscillator
- GOSS 76.67
- UPXI 47.86
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.